Kalocyte: Funding, Investors & Team (Oct 2026)
Kalocyte is a healthcare biotech startup at the pre-clinical stage, specializing in designing artificial substitutes for red blood cells, primarily for trauma care. Their main product, ErythroMer, is a dried, bio-inspired artificial red blood cell that can be used when conventional stored red blood cells are not accessible, unwanted, or limited in quantity. Founded in 2016, Kalocyte is based in Baltimore, Maryland.
Kalocyte has raised $310k across 3 funding rounds on record, the most recent an undisclosed round of $10k announced in Aug 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kalocyte Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Kalocyte Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Kalocyte raised $300k in an undisclosed round announced in Jun 2020.
2.1 years later, a Seed was announced in Jul 2022 with no disclosed amount.
1.1 years later, an undisclosed round of $10k was announced in Aug 2023.
Kalocyte Founders and Leadership Team
Contact details for the Kalocyte team: 1 of 2 have an email address on file.
Start 14-day free trial →Kalocyte Funding Compared to Other Biotechnology Startups
Kalocyte's latest round of $10k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kalocyte in Biotechnology and Baltimore
Companies Similar to Kalocyte
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Kalocyte Funding FAQs
What does Kalocyte do?
Kalocyte is a healthcare biotech startup at the pre-clinical stage, specializing in designing artificial substitutes for red blood cells, primarily for trauma care. Their main product, ErythroMer, is a dried, bio-inspired artificial red blood cell that can be used when conventional stored red blood cells are not accessible, unwanted, or limited in quantity. Founded in 2016, Kalocyte is based in Baltimore, Maryland.
How much funding has Kalocyte raised?
Kalocyte has raised $310k across 3 rounds on record. The most recent is an undisclosed round of $10k announced in Aug 2023.
When did Kalocyte last raise funding?
Kalocyte's most recent funding round on record is an undisclosed round of $10k, announced in Aug 2023.
Who founded Kalocyte?
FundedIQ lists Phil Spinella (Founder) at Kalocyte.
Who is the CEO of Kalocyte?
Elaine Haynes is listed as CEO at Kalocyte.
Where is Kalocyte headquartered?
Kalocyte is based in Baltimore, Maryland, United States.
How many employees does Kalocyte have?
Kalocyte is in the 11-50 employee band.
How does Kalocyte's funding compare to other Biotechnology startups?
Kalocyte's latest round of $10k is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Kalocyte Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kalocyte is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.